UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039630
Receipt number R000045199
Scientific Title Effect of neuromuscular electrical stimulation on individual quadriceps muscle atrophy in patients with non-weight bearing: A randomized control study
Date of disclosure of the study information 2020/03/01
Last modified on 2020/02/28 15:16:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of neuromuscular electrical stimulation on individual quadriceps muscle atrophy in patients with non-weight bearing: A randomized control study

Acronym

Effect of neuromuscular electrical stimulation on individual quadriceps muscle atrophy

Scientific Title

Effect of neuromuscular electrical stimulation on individual quadriceps muscle atrophy in patients with non-weight bearing: A randomized control study

Scientific Title:Acronym

Effect of neuromuscular electrical stimulation on individual quadriceps muscle atrophy

Region

Japan


Condition

Condition

Ankle and foot fractures

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the efficacy of neuromuscular electrical stimulation against quadriceps muscle atrophy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Individual QM thicknesses are measured 1 week after starting non-weight bearing, immediately before starting weight bearing, and the end of rehabilitation.

Key secondary outcomes

Clinical symptoms are assessed with patients-reported outcome measures: the SAFE-Q at the end of rehabilitation. Strengthening and tightness of QM are measured at the end of rehabilitation.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

During non-weight bearing, home exercises are performed by themselves; open kinetic chain exercises including knee flexion and extension, and hip abduction and adduction 30 times per day.

Interventions/Control_2

In addition to the home exercises, neuromuscular electrical stimulation is performed during knee flexion and extension exercise for 10 minutes twice per a week at hospital during non-weight bearing.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Inclusion criteria is a patient who are diagnosed as ankle and foot fractures by orthopedic examinations, who are required conservative therapy including non-weight bearing and ankle immobilization using cast for 4 weeks.

Key exclusion criteria

Exclusion criteria is a patient with a history of the leg fracture and surgeries, and hip and/or knee osteoarthritis.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Koun
Middle name
Last name Yamauchi

Organization

Akita hospital

Division name

Department of orthopedic surgery

Zip code

4720056

Address

2-6-12 Takara, Chiryu City, Aichi, Japan

TEL

0566-81-2763

Email

koun_mail_world@yahoo.co.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Yamada

Organization

Akita hospital

Division name

Research support division

Zip code

4720056

Address

2-6-12 Takara, Chiryu City, Aichi, Japan

TEL

0566-81-2763

Homepage URL


Email

a-ijika@akitahospital.or.jp


Sponsor or person

Institute

Akita hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Akita hospital IRB

Address

2-6-12 Takara, Chiryu City, Aichi, Japan

Tel

0566-81-2763

Email

a-ijika@akitahospital.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 02 Month 05 Day

Date of IRB

2020 Year 02 Month 25 Day

Anticipated trial start date

2020 Year 03 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 28 Day

Last modified on

2020 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045199


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name